(108 days)
The PM-1000F+ Patient Monitor is a vital signs monitor used on human patients. The target populations are adult, pediatric and neonatal patients.
The patient parameters that can be monitored with the PM-1000F+ Patient Monitor are ECG(3-lead or 5-lead selectable), Heart rate (HR), Pulse Rate (PR), Respiration rate (RESP), Non-invasive blood pressure (NIBP), Saturation of Pulse Oxygen (SpO2), Temperature (TEMP), Invasive Blood pressure (IBP), Carbon dioxide (CO2) and Anaesthetic gases (AG). Its design allows the operator to adjust the settings of parameter alarms that audibly and visually notify the operator when an excursion occurs.
This monitor is intended for use in a health care facility setting. It is intended for use by qualified medical personnel trained in the use of the equipment.
The PM-1000F+ Patient Monitor is not recommended for use in a patient's home or residence, or when it has not been ordered by a physician.
The PM-1000 F+ Patient Monitor is a battery or line-powered patient monitor. The Patient Monitor acquires the physiological signals such as ECG, respiration (RES), non-invasive blood pressure (NIBP), saturation of pulse oxygen (SpO2), temperature (TEMP), invasive pressure (IBP), carbon dioxide (CO2) and anesthetic gases (AG). These physiological signals are converted into digital data and processed. The PM 1000F+ Patient Monitor examines the data for alarm conditions and presents them on the color TFT display. The Patient Monitor also provides advantageous operating control for the user. The optional built-in recorder, the optional CF memory card provides hard copies of all digital data and waveforms as well as tabular and graphic trend information, and storage the previous monitoring data information when power off accidentally.
The provided document, a 510(k) summary, describes a patient monitor (PM-1000F+) and asserts its substantial equivalence to predicate devices. However, it does not explicitly detail a study conducted to demonstrate the device meets specific acceptance criteria with reported performance metrics. Instead, it describes compliance through testing against established standards and comparison to predicate devices.
Here's an analysis based on the available information:
1. Table of Acceptance Criteria and Reported Device Performance:
The document does not provide a table with specific acceptance criteria (e.g., minimum accuracy percentages for parameters) and the PM-1000F+ Patient Monitor's reported performance against those criteria. Instead, it states:
"Testing was conducted to validate and verify that the PM-1000F+ Patient Monitor met all design specifications and was substantially equivalent to the predicate devices. Testing was performed to demonstrate compliance with the ANSI/AAMI standards EC13-2002, "Cardiac monitors, heart rate meters, and alarms." The PM-1000F+ has also been tested to assure compliance with the requirements of various published standards, including IEC60601-1, IEC60601-1-1, IEC60601-1-2, IEC60601-1-4, IEC60601-2-27, IEC60601-2-30 and ISO14971."
This indicates that the acceptance criteria are implicitly defined by compliance with these international and national standards for medical electrical equipment and specific performance requirements for cardiac monitors. The "reported device performance" is summarized as having "met all design specifications" and being "substantially equivalent" to predicate devices, rather than detailed quantitative results.
2. Sample Size Used for the Test Set and Data Provenance:
The document does not specify a "test set" in the context of clinical data for a study. The testing described is against established standards. Therefore, information about sample size and data provenance (country of origin, retrospective/prospective) for a clinical test set is not provided.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:
As no clinical test set with associated ground truth established by experts is described, this information is not applicable and not provided.
4. Adjudication Method for the Test Set:
Since a clinical test set requiring expert adjudication is not described, this information is not applicable and not provided.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance:
The PM-1000F+ Patient Monitor is a vital signs monitor, not an AI-assisted diagnostic device that would involve human "readers" or an AI component designed to improve human interpretation. Therefore, an MRMC comparative effectiveness study with AI assistance is not applicable and not mentioned.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done:
The PM-1000F+ is a patient monitor that directly measures physiological signals and processes them for display and alarm generation. It doesn't present an "algorithm-only" performance scenario in the way an AI diagnostic tool might. The device's performance is tested against established standards for accuracy and reliability of its measurements (ECG, NIBP, SpO2, etc.). While its processing of signals represents an "algorithm," the document doesn't break down testing into a standalone algorithm performance versus human-in-the-loop in the context of a typical AI submission. Its "standalone" performance is implicitly covered by the compliance testing to the listed standards.
7. The Type of Ground Truth Used (Expert Consensus, Pathology, Outcomes Data, etc.):
For a physiological monitor, the "ground truth" for its measurements (e.g., heart rate, blood pressure, oxygen saturation) is typically established by reference methods or simulators that are themselves validated and considered accurate. For example, during NIBP testing, a manometer might be considered the ground truth. The document broadly states "Testing was conducted to validate and verify that the PM-1000F+ Patient Monitor met all design specifications," implying that the measurements taken by the device were compared against such established reference standards or methods. However, specific details of the ground truth for each parameter are not explicitly described beyond compliance with relevant standards.
8. The Sample Size for the Training Set:
The PM-1000F+ Patient Monitor is a traditional medical device, not an AI/Machine Learning device that undergoes a "training" phase with a dataset. Therefore, the concept of a "training set" is not applicable and not mentioned.
9. How the Ground Truth for the Training Set Was Established:
Since there is no "training set," this information is not applicable.
In summary:
The provided 510(k) summary focuses on demonstrating substantial equivalence through adherence to recognized performance and safety standards for patient monitors and comparison to predicate devices, rather than detailing a clinical study with specific acceptance criteria, sample sizes, and expert adjudication as might be found in an AI/diagnostic device submission.
{0}------------------------------------------------
510(K) Summary
JAN 1 6 2009
This summary of 510(k) safety and effectiveness information is being submitted ın accordance with the requirements of SMDA 1990 and 21 CFR 807 92
The assıgned 510(k) number ıs K082887
| Submitter / Distributor | Advanced Instrumentations, Inc6800 N W 77th CourtMiami, Fl 33166 | ||
|---|---|---|---|
| Registration # 1066270 | |||
| TelephoneFax | 305-477-6331305-477-5351 | ||
| Contact Person: | Jorge Millan, PhDEmail jmillan@hiatec org | ||
| Manufacturer | Shenzhen Mindray Bio-medical Electronics Co , LTDMindray Building, Keji 12th Road South, Hi-techIndustrial Park, Nanshan, Shenzhen, 518057, P RChina | ||
| Registration # | 3004365718 | ||
| TelFax | + 86-755-2658-2888+ 86-755-2658-2680 |
- January 15, 2009 Date Prepared .
Name of the device:
- Trade/Proprietary Name PM-1000F+ Patient Monitor .
- Patient Monitor Common Name: .
Classification. .
| 21 CFR 870 2300 | Cardiac monitor (including cardiotachometer and rate alarm) | Class I |
|---|---|---|
| 21 CFR 870 1025 | Arrhythmia detector and alarm | Class I |
| 21 CFR 870 1025 | Detector and Alarm, Arrhythmia | Class I |
| 21 CFR 870 1025 | Monitor, ST Segment with Alarm | Class I |
| 21 CFR 870 1130 | Non-Invasive blood pressure measurement system | Class I |
| 21 CFR 870 1110 | Blood pressure computer | Class I |
{1}------------------------------------------------
| 21 CFR 870 2910 | Clinical Electronic Thermometers-Temperature Monitor with Probe | Class II |
|---|---|---|
| 21 CFR 870 2700 | Oximeter, Pulse | Class II |
| 21 CFR 870 2710 | Ear Oximeter, Pulse | Class II |
| 21 CFR 868 1400 | Carbon Dioxide Gas Analyzer | Class II |
| 21 CFR 868 1500 | Enflurane gas analyzer | Class II |
| 21 CFR 868 1620 | Halothane gas analyzer | Class II |
| 21 CFR 868 1700 | Nitrous Oxide gas analyzer | Class II |
| 21 CFR 868 1720 | Oxygen gas analyzer | Class II |
Legally Marketed Predicate Device.
- PM-8000 Patient Monitor, Shenzhen Mindray Bro-medical K043348 Electronics Co . Ltd
- PM-9000 Express Patient Monitor, Shenzhen Mindray Bio-medical K053234 Electronics Co . Ltd
- PM Series Patient Monitors, Shenzhen Mindray Bıo-medical K070791 Electronics Co . Ltd
Device Description.
The PM-1000 F+ Patient Monitor is a battery or line-powered patient monitor The Patient Monitor acquires the physiological signals such as ECG, respiration (RES), non-invasive blood pressure (NIBP), saturation of pulse oxygen (SpO2), temperature (TEMP), invasive pressure (IBP), carbon dioxide (CO2) and anesthetic gases (AG) These physiological signals are converted into digital data and processed The PM 1000F+ Patient Monitor examines the data for alarm conditions and presents them on the color TFT display The Patient Monitor also provides advantageous operating control for the user The optional built-in recorder, the optional CF memory card provides hard copies of all digital data and waveforms as well as tabular and graphic trend information, and storage the previous monitoring data information when power off accidentally
Statement of Intended Use.
The PM-1000F+ Patient Monitor is a vital sıgns monıtor used on human patıents The target populations are adult, pediatric and neonatal patients The PM-1000F+ Patient Monitor has many features and functions Its use is through an ıntegrated keypad. knob, and intuitive menu system
The patient parameters that can be monitored by the PM-1000F+ are ECG (3-Lead or 5-Lead selectable), arrhythmia detection, ST segment analysis Heart Rate (HR), Respiration Rate (RESP), Non-invasive Blood Pressure (NIBP), Pulse Oxygen Saturation (SpO2), Temperature (TEMP), Invasive Blood Pressure (IBP), Carbon Dioxide (CO2), and Anaesthetic Gases (AG) Its design allows the operator to adjust the settings of parameter alarms that audibly and visually notify the operator when an excursion occurs
{2}------------------------------------------------
The PM-1000F+ Patient Monitor is intended for use in hospital clinical areas such as intensive care units, cardiac care units, operating room, emergency department, to provide additional information to the medical and nursing staff about the physiological condition of the patient The PM-1000F+ Patient Monitor ıs intended to be used only under regular supervision of clinical personnel and by qualified medical personnel trained in the use of the equipment The intended location of use is clinics The PM-1000F+ Patient Monitor is not intended or recommended for use in a patient's home or residence, or when it has not been ordered by a physician
Comparison of Technological Characteristics:
The PM-1000F+ Patient Monitor is substantially equivalent to systems currently marketed predicate devices The design, components, storage technology and energy source the PM-1000F+ Patient Monitor are similar to the predicate devices The PM-1000F+ provides a means for interfacing with a patient, collecting parameter specific physiological data, and processing the data for alarm generation and display of numeric values and waveforms on a bedside or central monitoring system The parameter's specification of the PM-1000F+ ıncludıng ECG, RESP, HR, PR, RESP, NIBP, SpO2, CO2, TEMP, IBP, IS ıdentıcal to the predicate devices
Testing
Testing was conducted to validate and verify that the PM-1000F+ Patient Monitor met all design specifications and was substantially equivalent to the predicate devices Testing was performed to demonstrate compliance with the ANSI/AAMI standards EC13-2002, "Cardiac monitors, heart rate meters, and alarms " The PM-1000F+ has also been tested to assure compliance with the requirements of various published standards, including IEC60601-1, IEC60601-1-1, IEC60601-1-2, IEC60601-1-4, IEC60601-2-27, IEC60601-2-30 and ISO14971
Conclusion:
The conclusions drawn form clinical and bench testing of the PM-1000F+ Patient Monitor demonstrates that the device is as safe, as effective, and performs as well to the legally marketed predicate device
{3}------------------------------------------------
Image /page/3/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a stylized human figure.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Advanced Instrumentations, Inc c/o Jorge Millan, PhD Hialeah Technology Center 601 W 20th Street Hialeah, FL 33010
JAN 1 6 2009
K082887 Re
PM-1000F+ Patient Monitor Regulation Number 21 CFR 870 2300 Regulation Name Cardiac monitor (including cardiotachometer and alarm) Regulatory Class Class II (two) Product Code DSIMWI Dated December 22, 2008 Received December 22, 2008
Dear Dr Mıllan
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA) You may, therefore, market the device, subject to the general controls provisions of the Act The general controls provisions of the Act include requirements for annual registration, Insting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898 In addition, FDA may publish further announcements concerning your device in the Federal Register Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807), labeling (21 CFR Part 801), good manufacturing practice requirements as set
1151-1600 - 115 11 25 25 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11
{4}------------------------------------------------
Page 2- Dr Jorge Millan
forth in the quality systems (QS) regulation (21 CFR Part 820), and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act), 21 CFR 1000-1050 This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120 Also, please note the regulation entitled, "Mısbrandıng by reference
to premarket notification" (21CFR Part 807 97) You may obtain other general information on your responsibilities under the Dryision of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http //www fda gov/cdrh/industry/support/index html
Sincerely yours,
and the may be the state of the minister
Bram D Žuckerman, M D Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
IKE LA 18 12 2017
{5}------------------------------------------------
Indications for Use
510(k) Number (if known) K082887
Device Name
PM-1000F+ Patient Monitor
Indications For Use
The PM-1000F+ Patient Monitor is a vital signs monitor used on human patients The target populations are adult, pediatric and neonatal patients
The patient parameters that can be monitored with the PM-1000F+ Patient Monitor are ECG(3-lead or 5-lead selectable), Heart rate (HR), Pulse Rate (PR), Respiration rate (RESP), Non-invasive blood pressure (NIBP), Saturation of Pulse Oxygen (SpO2), Temperature (TEMP), Invasive Blood pressure (IBP), Carbon dioxide (CO2) and Anaesthetic gases (AG) Its design allows the operator to adjust the settings of parameter alarms that audibly and visually notify the operator when an excursion occurs
This monitor is intended for use in a health care facility setting It is intended for use by qualified medical personnel trained in the use of the equipment
The PM-1000F+ Patient Monitor is not recommended for use in a patient's home or residence, or when it has not been ordered by a physician
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
510(k) Number K082587
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).